期刊文献+

建立硬皮病小鼠模型的实验研究 被引量:12

Experimental study of establishing mouse model for scleroderma
原文传递
导出
摘要 目的 建立硬皮病小鼠模型。方法 取雌性BALB/C和C3H小鼠各 14只 ,平均分为造模组1和对照组。造模组1用 2 0 0 μg/ml的博来霉素 (bleomycin ,BLM ) 0 1ml注射于小鼠背部皮肤 ,每日 1次 ,共 3周 ;对照组用磷酸盐缓冲液 (PBS) 0 1ml作背部皮内注射 ,每日 1次 ,共 3周 ;观察两组皮肤和肺组织学改变 ,应用医学彩色病理图象分析系统测定真皮厚度 ;用光电比色法测定皮肤中羟脯氨酸和蛋白的含量来推断胶原含量 ;进行Ⅰ、Ⅲ型胶原和转化生长因子 (TGF) β1免疫组织化学染色 ,计算了免疫组织化学指数。用SPSS软件对两组的检测值作统计学分析。结果 造模组1小鼠的皮肤厚度较对照组明显增厚 (P <0 0 0 1)。皮肤胶原含量比对照组显著增高 (P <0 0 5 )。皮肤Ⅰ、Ⅲ型胶原免疫组织化学指数比对照组明显增加 (P <0 0 0 1)。皮肤TGF β1免疫组织化学指数比对照组亦有极明显增加 (P <0 0 0 1)。结论  2 0 0 Objective To establish a mouse model for scleroderma.Methods Forteen BALB C and 14 C3H female mice were averagely divided into model 1 and controls.Daily 0 1 ml BLM at a concentration of 200 μg/ml was injected intracutaneusly into the backs of model 1 mice for 3 weeks,and 0 1 ml solution of PBS were injected intracutaneusly into the backs of control mice for 3 weeks.Observing the histological change of skin and lungs was made and measuring the thickness of dermis was performed with a medical analysis system of the color picture,determined the collagenic quantity was done with photoelectric colorimetry,and calculating the immunohistochemical index of collagen type Ⅰ and Ⅲ and transforming growth factor β 1 (TGF β 1) in the skin lesions from the mouse model and control was done.SPSS was used to finish the statistical analysis of the detective value from model 1 and controls.Results In the skin of model mice,the thickness of dermis markedly thickened ( P <0 001),collagenic quantity obviously increased ( P <0 05),and immunohistochemical index of collagen type Ⅰ and Ⅲ and TGF β 1 all markedly increased ( P <0 001) more than those of controls.Conclusion The animal model of scleroderma can be successfully established in BALB C and C3H mice with BLM at a concentration of 200 μg/ml.
出处 《中华风湿病学杂志》 CAS CSCD 2003年第8期478-481,T001,共5页 Chinese Journal of Rheumatology
关键词 硬皮病 小鼠模型 实验研究 博来霉素 Mice,inbred C3H Mice,inbred BALB C Scleroderma,circumscribed Bleomycin
  • 相关文献

参考文献11

  • 1曹元华,靳培英.用博来霉素建立硬皮病动物模型及其应用[J].国外医学(皮肤性病学分册),2001,27(6):344-346. 被引量:7
  • 2Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol,1999,112:456-462.
  • 3Kasturi N, Shibata S, Muryoi T, et al. Tight skin mouse: an experimental model for scleroderma, Int Rev Immunol, 1994, 11: 253-271.
  • 4Judy VD, Gershwin ME. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis. Am J Pathol, 1985,120 : 478-482.
  • 5Bennett JP, Burns CP. Absence of progress of recurrent bleomycin skin toxicity without postponement or attenuation of therapy. Am J Medicine, 1988,85 : 585-586.
  • 6Yamamoto T, Katayama I, Nishioka K. Fibroblast proliferation by bleomycin stimulated perpheral blood mononuclear cell factors. J Rheumatol, 1999,26 : 609-615.
  • 7Oder WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med, 1994,331 : 1286-1292.
  • 8Karukonda SR, Flynn TC, Boh EE, et al. The effects of drugs on wound healing: part 1. Int J Dermatol, 2000,39 : 250-257.
  • 9Higley H, Persichitte S, Chu S, et al. Immunocytochemical localization and serologic detection of transforming growth factor beta-1:association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum, 1994,37:278-288.
  • 10Kissin EY, Lemaire R, Kom JH, et al. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum, 2002,46 : 3000-3009.

二级参考文献15

  • 1山本俊一强皮症モデルの応用皮膚病診瘵,2000,22(11):1014-1017.
  • 2Fisman S,Russo GG.The toxic pseudosclerodermas.Int J Derrmatol,1991,30(12):837-842.
  • 3Varga J,Jimenez SA.Chemical exposure-induced cutaneous fibrosis.ArchDermatol,1994,130(1):97-100.
  • 4Yamamoto T,Takagawa S,Katayama I,et al.Animal model of sclerotic skin.Ⅰ:Local injections of bleomycin induce sclerotic skin mimicking scleroderma.J Invest Dermatol,1999,112:456-462.
  • 5Yamamoto T.Takagawa S,Katayama I,et al.Anti-sclerotic effect oftransforming growth factor- β antibody in a mousee model of bleomycin induced scleroderma.Clin Immunol,1999,92(1):6-13.
  • 6Hunzelmann N,Anders S.Fierllbeck G,et al.Multicenter trial of 1 yearof treatment with recombinant interferon gamma.Arch Dermatol,1997,133(5):609-613.
  • 7Yamamoto T,Takagawa S,Kuroda M,et al.Effect of interferon-ron exper-imental scleroderma induced by bleomycin.Arch Dermatol,2000,292:362-365.
  • 8Black CM,Silman A J,Herrick AI,et al.Interferon-α does not improveoutcome at one year in patients with diffuse cutaneous scleroderma..Arthri-tis Rheum,1999,42:299-305.
  • 9Boeder WA,Noble NA.Transforming growth factor βin tissue fibrosis.N Engl J Med,1994,331(19):1286-1292.
  • 10Peltonen J,Kahari L,Jaakkola S,et al.Evaluation of transforming growth facter β and type Ⅰ procollagen gene expression in fibrotic skin dieases by situ hybridization.J Invest Dermatol,1990,94(3):365-371.

共引文献6

同被引文献87

引证文献12

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部